Atrial fibrillation is a type of irregular heartbeat that can cause blood clots to form in your heart. Having atrial fibrillation increases your risk of stroke by five times.
People with a type of irregular heartbeat called atrial fibrillation (AF) are five times more likely to have a stroke. This guide explains what AF is diagnosed, how it increases your risk of stroke and how it is treated.
A leaflet for professionals about atrial fibrillation, how to identify patients affected by the condition and how to manage AF in your community.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
This study will investigate whether early initiation of direct anticoagulant drugs will be as safe as later initiation in stroke patients with an abnormal heart rhythm (atrial fibrillation). It will also investigate whether early initation could lead to fewer recurrent strokes.
Techniques to predict - and in future prevent - brain haemorrhage in people treated with warfarin after stroke caused by atrial fibrillation
Information about atrial fibrillation for healthcare and other professionals.
During February and March pharmacies across Wales are joining the Lower Your Risk of Stroke campaign, a partnership between Community Pharmacy Wales, Public Health Wales and the Stroke Association.
Published in the journal Age and Ageing, a new systematic review of the current research suggests that anticoagulant drugs may have cognitive benefit for those with AF (atrial fibrillation).
Gareth Davies had a stroke because of high blood pressure and is supporting a new campaign from the Stroke Association which aims to reduce the number of strokes across Wales.